News Room

 

Industry News

See how our industry contributes to the development of harmonized norms and standards that enable an adequate quality, safety, and efficacy control of medical products globally...

This #WorldHealthDay, @IFPMA highlights that health is a sound investment in human capital, making individuals, communities and economies thrive....

This #WorldHealthDay join us in spreading the word that quality #healthcare and #UHC brings well-being to families, enables children to learn and adults to earn 🙌🏿🏥🌍📈...

Investing in #UHC is an investment in #people, a country’s most valued asset....

What does it take to make #UHC truly “universal”? #WorldHealthDay ...

Globally, over 2.7 billion women, mothers and adolescent girls are legally denied access to education, jobs and most importantly healthcare. In some countries they still cannot access health services without spousal or parental permission. There is no doubt that women bear the brunt of health inequities. A holistic approach around ‘smart economics’ is needed to address this gap. ...

The role that pharmaceutical companies play in improving the health and welfare of the general population is one that is often overlooked. Not only do their medicines save lives, improve health, and prolong and enhance the quality of life, but medicines also have the potential to reduce overall healthcare costs by speeding up recovery times, as well as the need for surgery and hospitalisation....

Xolani Gwala hosted the second edition of #Change4Cancer. Joining him was a panel of various stakeholders who looked at the many answered questions related to the disease. They looked at matters relating to access to quality treatment, early screening and detection, behavioural change and alternative......

Please see the document below for the new appointments to the executive board of IPASA. IPASA New EXCO Release 12 November 2018...

Draft IP Policy – Phase I IPASA Cover Letter 171117 NHI Implementation Structure – IPASA Submission 20171130 NHI Implementation Structures – IPASA Cover Letter POPI Regulations – IPASA Comments 171107 POPI Regulations – IPASA Cover Letter Revised Draft IP Policy – IPASA Narrative Submission 171117......

Media Release 2019

Colleen Purdy is the Amgen GM for South Africa. She joined Amgen in 2012 and was tasked with setting up and establishing an affiliate based in Johannesburg. Prior to this Colleen worked in various commercial roles in South Africa for Batswadi, Janssen, Schering-Plough, Madaus and......

Daniel Binette has been appointed Managing Director of Lilly South Africa. His career at Lilly spans 18 years where 15 were spent in Canada in various commercial roles. He is known as a strategic, dynamic, customer focused and results-oriented leader with multiple launch experiences. Before......

Thierry Brule Joined AbbVie South Africa as General Manager for South Africa and Region Africa in 2018. He has 15 years of industry experience across multiple functions, across major Therapeutic Areas (from Oncology, Hematology, Neonatology and Immunology to Virology, Respiratory and Ophthalmology), in Europe, in......

Rhulani Nhlaniki is the Cluster Lead for Sub-Saharan Africa and Country Manager for South Africa at Pfizer. He joined Pfizer in 2016 and previously assumed the role of Innovative Health Cluster Lead for the Sub-Saharan Africa. With over 18 years’ experience in the pharmaceutical industry,......

Media Release 2018

Erika Koppers joined Shire as Country Lead, South Africa in November 2016 to establish the legal entity and set up operations as Shire Pharmaceuticals SA. Prior to joining Shire, Erika worked at AstraZeneca and Roche covering various commercial roles with local and Sub-Sahara responsibilities across......

Emma Knox joined GSK UK in 2004. She has held a variety of roles in Sales, Marketing and Market Access across Europe, Emerging Market and more recently in Southern Africa. She moved to South Africa in 2012 where she took on the role of Marketing......

Thibault Crosnier_Leconte joined Sanofi South Africa in 2016 as the Country Chair and RX General Manager for South Africa, Namibia & Botswana. He has 17 years of industry experience, which includes leadership positions at Sanofi in the UK and in Russia, where he served as......

Media Release 2017

Media Release 2014